$ABEV · AMBEV S.A.
Ambev reported Q3 2026 results with consolidated organic net revenue up 7.6% and Normalized EBITDA up 8.9% organically, reaching R$7,270.9M. Normalized EPS rose 15.4% to R$0.28. The Board approved a 190-million-share buyback program (~R$2.9B) to be executed over 18 months.
- Normalized EBITDA grew 8.9% organically to R$7,270.9M, with margin expanding 40 bps to 33.7%.
- Normalized EPS rose 15.4% to R$0.28, driven by EBITDA growth and lower net financial expenses.
- Board approved a buyback of up to 190M shares (~R$2.9B) over 18 months.
- Cash flow from operations jumped 11.0% to R$7,677.9M, aided by improved working capital.
- Brazil Beer volumes grew 0.5% in Q3, outperforming the industry on a combined Q2-Q3 basis (+2.7% vs. +1.3%).
Markets closed — no regular-session reaction yet; extended-hours move not captured here. The buyback authorization (190M shares, ~R$2.9B) and broad-based organic growth across all business units provide a positive setup for the next session.
Ambev delivered broad-based organic growth across all five business units, margin expansion, and a substantial buyback — a trifecta that strengthens the bull case for the $42.9B brewer.
Ambev's results mirror broader EM consumer staples trends: pricing-led revenue growth offsetting sluggish volumes. The 190M-share buyback signals confidence in cash generation despite currency headwinds in Argentina.
Argentina hyperinflation accounting (IAS 29) required capping price growth to 2%/month for organic calculations, masking true LAS volatility. Commodity headwinds and FX exposure persist, though FY2027 BRL/USD hedges are already in place.